STRS Ohio’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

STRS Ohio’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-56	Closed	–	–	2224
2019 Q1	$0	Hold	56	–	–	﹤0.01%	2114
2018 Q4	$0	Hold	56	–	–	﹤0.01%	2153
2018 Q3	$1K	Hold	56	–	–	﹤0.01%	2100
2018 Q2	$2K	Hold	56	–	–	﹤0.01%	2106
2018 Q1	$3K	Hold	56	–	–	﹤0.01%	1866
2017 Q4	$4K	Hold	56	–	–	﹤0.01%	1864
2017 Q3	$5K	Hold	56	–	–	﹤0.01%	1905
2017 Q2	$3K	Hold	56	–	–	﹤0.01%	1919
2017 Q1	$12K	Hold	56	–	–	﹤0.01%	1847
2016 Q4	$5K	Hold	56	–	–	﹤0.01%	1900
2016 Q3	$7K	Hold	56	–	–	﹤0.01%	1879
2016 Q2	$5K	Hold	56	–	–	﹤0.01%	1903
2016 Q1	$9K	Sell	56 -2,444	-98%	-$495K	﹤0.01%	1862
2015 Q4	$818K	Buy	2,500 +467	+23%	+$152K	﹤0.01%	930
2015 Q3	$655K	Sell	2,033 -189	-9%	-$83K	﹤0.01%	1102
2015 Q2	$885K	Buy	2,222 +589	+36%	+$250K	﹤0.01%	945
2015 Q1	$804K	Buy	+1,633	New	+$633K	﹤0.01%	915
2014 Q4	–	Sell	-700	Closed	-$135K	–	1822
2014 Q3	$135K	Buy	700 +122	+21%	+$26.8K	﹤0.01%	1523
2014 Q2	$138K	Buy	578 +45	+8%	+$9.15K	﹤0.01%	1508
2014 Q1	$136K	Hold	533	–	–	﹤0.01%	1506
2013 Q4	$106K	Sell	533 -1,089	-67%	-$194K	﹤0.01%	1556
2013 Q3	$274K	Sell	1,622 -667	-29%	-$107K	﹤0.01%	1398
2013 Q2	$406K	Buy	+2,289	New	+$324K	﹤0.01%	1335

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

STRS Ohio's LUMO Position: Q2 2019 in Review

STRS Ohio sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2019, closing a stake of 56 shares.

STRS Ohio first reported a position in LUMO in Q2 2013 and held it in 23 quarters. The position peaked at $885K in Q2 2015. 68 funds tracked by Wall St. Rank hold LUMO as of Q2 2019.

STRS Ohio reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
STRS Ohio sold 56 Lumos Pharma, Inc. Common Stock shares in Q2 2019.
STRS Ohio first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 23 quarters.
STRS Ohio's Lumos Pharma, Inc. Common Stock position peaked at $885K in Q2 2015.
68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2019.

Based on STRS Ohio's 13F filing for Q2 2019, filed 25 Jul 2019.